Cancer studies
Cancer clinical trials start with a conversation
Oncology Research Hub is a service for people who want to understand cancer clinical trials, whether for themselves or for someone they care for. If you are interested, we connect you with study teams. The first step is a short conversation. It costs nothing, and it places you under no obligation.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed

Cancer studies in numbers
- cancer studies recruiting in the U.S.
- 3,223
- states with a study site
- 51
- cities with a study site
- 1,597
- studies that accept healthy volunteers
- 254
Source: ClinicalTrials.gov. Data processed .
Find cancer studies near you
These states have the most studies recruiting right now.
California
984 studies recruiting.
Texas
894 studies recruiting.
New York
861 studies recruiting.
Florida
706 studies recruiting.
Ohio
542 studies recruiting.
All locations
Browse every state and city with a recruiting study.
Cancer studies recruiting now
As of November 16, 2026, 3,223 cancer studies are recruiting participants in the United States, according to ClinicalTrials.gov. This is what they have in common.
What they test
- medications1,850
- other approaches635
- procedures558
- biologics such as vaccines or antibodies425
- radiation262
A study can test more than one.
Main purpose
- treating a condition2,051
- supportive care225
- diagnosis138
- how care is delivered73
Phase
- Early Phase 160
- Phase 1539
- Phase 1/2407
- Phase 2794
- Phase 2/332
- Phase 3242
- Phase 439
- No phase597
- Observational513
Studies of devices and behavioral approaches have no phase.
Who runs them
- university, hospital or other2,153
- industry913
- government157
Who they enroll
- adults (18 to 64)3,178
- older adults (65 and over)3,074
- children (under 18)284
254 also accept healthy volunteers.
Where: sites in 51 states. The cities with the most are New York, NY (649), Houston, TX (624), Boston, MA (467), Los Angeles, CA (384), Nashville, TN (344), Chicago, IL (337), Philadelphia, PA (296), St Louis, MO (287).
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 3,223 studies.
Recruiting now, by research area
- Breast Cancer: 921 studies recruiting in the United States.
- Lung Cancer: 885 studies recruiting in the United States.
- Prostate Cancer: 594 studies recruiting in the United States.
- Melanoma: 245 studies recruiting in the United States.
- Lymphoma: 731 studies recruiting in the United States.
- Pancreatic Cancer: 380 studies recruiting in the United States.
Recently updated cancer studies
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- University of Texas Southwestern Medical Center
- Recruiting in
- Dallas, TX · Neptune City, NJ · Pittsburgh, PA · and 2 more U.S. locations
- Registry record
- NCT02468024 · updated
Molecular Analysis of Childhood and Adolescent Melanocytic Lesions
- Observational
- Up to age 18
- All sexes
- Sponsor
- St. Jude Children's Research Hospital
- Recruiting in
- Memphis, TN
- Registry record
- NCT02775643 · updated
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
- Phase 2
- Ages 12 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bethesda, MD
- Registry record
- NCT03258567 · updated
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Phase 2
- Ages 18 and older
- Male participants
- Sponsor
- VA Office of Research and Development
- Recruiting in
- Ann Arbor, MI · Aurora, CO · Boise, ID · and 12 more U.S. locations
- Registry record
- NCT04038502 · updated
Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- John Reneau
- Recruiting in
- Columbus, OH
- Registry record
- NCT04848064 · updated
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- M.D. Anderson Cancer Center
- Recruiting in
- Houston, TX
- Registry record
- NCT05011045 · updated
Source: ClinicalTrials.gov. Data processed .
Not sure which study fits?
Tell a coordinator what you are looking for. They will explain which cancer studies may be worth a closer look and what the next step is. Asking does not commit you to anything.
How taking part works
There are four steps. At each one, you choose whether to go on to the next.
Tell us what you are looking for
You call us or send a short form. Tell us the condition or the kind of study you want to know about, whether it is for you or for a family member.
Talk with a coordinator
A coordinator tells you which cancer studies may be a match. Any questions you have are answered in plain language.
Meet the study team
The next step happens only if you want it. The study team goes through the study with you in detail and checks whether you are eligible.
Decide what is right for you
Joining a study is your decision, always. If you change your mind, you can leave at any time and for any reason.
Research areas
These are the areas of cancer research we help people look into.
Breast Cancer studies
In breast cancer, studies look at investigational medications, at existing therapies used in combination, and at approaches to screening or supportive care.
Lung Cancer studies
Research in lung cancer covers different types and stages of the disease. It examines investigational medications, radiation approaches, and screening methods.
Prostate Cancer studies
Across the stages of prostate cancer, studies evaluate investigational medications, imaging methods, and approaches to monitoring.
Melanoma studies
Melanoma is a form of skin cancer. Research here examines investigational immunotherapies, targeted medications, and combinations.
Lymphoma studies
For Hodgkin and non-Hodgkin lymphoma, studies evaluate investigational medications as well as cell-based approaches.
Pancreatic Cancer studies
In pancreatic cancer, research looks at investigational medications, therapies given in combination, and methods of early detection.
Not sure where you fit?
A coordinator can point you in the right direction. All we need is a little information about what you, or the person you are helping, are looking for.
Why people take part in cancer studies
The reasons for joining a cancer research study differ from person to person. Every one of them is a good thing to talk through before you or your family member decides.
- Some want a research team to follow their health closely while the study is running.
- Some want to understand more about a condition they live with.
- Some want to help researchers answer questions that may shape the care other people receive in the future.
A study is research. It is not treatment, and nobody can promise that taking part will help you personally. For a plain explanation, read what a clinical trial is.
Your safety and your rights come first
No study can enroll a single person until an independent ethics committee has reviewed it. That review comes first. You, or the family member you are reading for, will also have the written details in hand, and nothing is agreed until you do. These pages explain the informed consent process, the review and monitoring each study goes through, and the rights that stay with you from the first day to the last.
Common questions about cancer studies
Does it cost anything to ask about a study?
No. A conversation with Oncology Research Hub costs you nothing. Asking questions, for yourself or for a relative, does not sign anyone up for anything.
Do I have to take part if I call?
No. Every step is yours to decide, including whether to go further. Stopping is possible at any time.
Who decides whether I can join a study?
The study team makes that call, and only once a screening visit is complete. Requirements are set separately for every study. Read about eligibility and screening.
Ask about cancer studies
A coordinator will contact you once you share a few details. Asking, for yourself or for someone you care for, commits you to nothing.
Learn more from independent sources
- What Are Clinical Trials and Studies? — National Institute on Aging (NIH)
- About Research Participation — HHS Office for Human Research Protections
- Learn About Studies — ClinicalTrials.gov (National Library of Medicine)